Oncogenic kinase signalling.

The hallmarks of cancer

Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219 · see citing works

Cell Signaling by Receptor Tyrosine Kinases

Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929 · see citing works

Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia

Druker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J., Lydon, N., Kantarjian, H. M., Capdeville, R., Ohno-Jones, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441401 · Cited by 5,237 · see citing works

Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors

Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K., Nishida, T., Ishiguro, S., Kawano, K., Hanada, M., Kurata, A., Takeda, M., et al. (1998) · Science · doi:10.1126/science.279.5350.577 · Cited by 4,487 · see citing works

Cellular survival: a play in three Akts

Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216 · see citing works

STATs and Gene Regulation

Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979 · see citing works

Cell Signaling by Receptor Tyrosine Kinases

Schlessinger, J. (2000) · Cell · doi:10.1016/s0092-8674(00)00114-8 · Cited by 3,774 · see citing works

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells

Druker, B. J., Tamura, S., Buchdunger, E., Ohno-Jones, S., Segal, G. M., Fanning, S., Zimmermann, J., & Lydon, N. (1996) · Nature Medicine · doi:10.1038/nm0596-561 · Cited by 3,618 · see citing works

Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome

Druker, B. J., Sawyers, C. L., Kantarjian, H., Resta, D. J., Reese, S. F., Ford, J. M., Capdeville, R., & Talpaz, M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441402 · Cited by 2,713 · see citing works

Signaling—2000 and Beyond

Hunter, T. (2000) · Cell · doi:10.1016/s0092-8674(00)81688-8 · Cited by 2,586 · see citing works

A minute chromosome in human chronic granulocytic leukemia

Nowell̀, P. C. (1960) · Science · Cited by 2,316 · see citing works

Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization

Diehl, J. A., Cheng, M., Roussel, M. F., & Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.22.3499 · Cited by 2,130 · see citing works

TOR, a central controller of cell growth.

Schmelzle, T., & Hall, M. (2000) · Cell · doi:10.1016/s0092-8674(00)00117-3 · Cited by 2,044 · see citing works

Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal Tumor

Joensuu, H., Roberts‎, P., Sarlomo‐Rikala, M., Andersson, L. C., Tervahartiala, P. O., Tuveson, D. A., Silberman, S., Capdeville, R., Dimitrijević, S., Druker, B. J., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441404 · Cited by 2,030 · see citing works

STATs in oncogenesis

Bowman, T., Garcia, R., Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203527 · Cited by 1,743 · see citing works

The molecular biology of chronic myeloid leukemia

Deininger, M. W., Goldman, J. M., & Melo, J. V. (2000) · Blood · doi:10.1182/blood.v96.10.3343 · Cited by 1,655 · see citing works

Dimerization of cell surface receptors in signal transduction

Heldin, C.-H. (1995) · Cell · doi:10.1016/0092-8674(95)90404-2 · Cited by 1,634 · see citing works

The PI3K‒PDK1 connection: more than just a road to PKB

Vanhaesebroeck, B., & Alessi, D. R. (2000) · Biochemical Journal · doi:10.1042/bj3460561 · Cited by 1,632 · see citing works

Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas

Schmidt, L. S., Duh, F.-M. C., Chen, F., Kishida, T., Glenn, G. M., Choyke, P. L., Scherer, S. W., Zhuang, Z., Lubensky, I. A., Dean, M. C., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-68 · Cited by 1,517 · see citing works

DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA

STEHELIN, D., VARMUS, H. E., BISHOP, J. M., & VOGT, P. K. (1976) · Nature · doi:10.1038/260170a0 · Cited by 1,321 · see citing works

The protein tyrosine kinase family of the human genome

Robinson, D. R., Wu, Y., & Lin, S. (2000) · Oncogene · doi:10.1038/sj.onc.1203957 · Cited by 1,179 · see citing works

Protein Tyrosine Kinase Structure and Function

Hubbard, S. R., & Till, J. H. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.373 · Cited by 1,176 · see citing works

PIK3CA is implicated as an oncogene in ovarian cancer

Shayesteh, L., Lu, Y., Kuo, W.-L., Baldocchi, R. A., Godfrey, T. E., Collins, C. C., Pinkel, D., Powell, B., Mills, G. B., & Gray, J. W. (1999) · Nature Genetics · doi:10.1038/5042 · Cited by 1,158 · see citing works

Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells

Zhou, B. P., Liao, Y., Xia, W., Spohn, B., Lee, M., & Hung, M. (2001) · Nature Cell Biology · doi:10.1038/35060032 · Cited by 1,135 · see citing works

Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor

Heinrich, M. C., Griffith, D., Druker, B. J., Wait, C. L., Ott, K. A., & Zigler, A. J. (2000) · Blood · doi:10.1182/blood.v96.3.925 · Cited by 1,066 · see citing works

Dysregulation of Apoptosis in Cancer

Reed, J. C. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2941 · Cited by 993 · see citing works

Catalytic specificity of protein-tyrosine kinases is critical for selective signalling

Songyang, Z., Carraway, K. L., Eck, M. J., Harrison, S. C., Feldman, R. A., Mohammadi, M., Schlessinger, J., Hubbard, S. R., Smith, D. P., Eng, C., et al. (1995) · Nature · doi:10.1038/373536a0 · Cited by 919 · see citing works

Activation of RET as a Dominant Transforming Gene by Germline Mutations of MEN2A and MEN2B

Santoro, M. M., Carlomagno, F., Romano, A., Bottaro, D. P., Dathan, N. A., Grieco, M., Fusco, A., Vecchio, G., Matoskova, B., Kraus, M. H., et al. (1995) · Science · doi:10.1126/science.7824936 · Cited by 835 · see citing works

A TEL-JAK2 Fusion Protein with Constitutive Kinase Activity in Human Leukemia

Penard‐Lacronique, V., Boureux, A., Della-Valle, V., Poirel, H. A., Quang, C. T., Mauchauffé, M., Berthou, C., Lessard, M., Berger, R., Ghysdael, J., et al. (1997) · Science · doi:10.1126/science.278.5341.1309 · Cited by 790 · see citing works

Protein–protein interactions define specificity in signal transductionPreprint

Pawson, T. J., & Nash, P. (2000) · Genes & Development · doi:10.1101/gad.14.9.1027 · Cited by 775 · see citing works

Role for the p53 homologue p73 in E2F-1-induced apoptosis

Irwin, M. S., Marín, M. C., Phillips, A. C., Seelan, R. S., Smith, D. I., Liu, W., Flores, E. R., Tsai, K. Y., Jacks, T., Vousden, K. H., et al. (2000) · Nature · doi:10.1038/35036614 · Cited by 710 · see citing works

Ribosomal S6 Kinase Signaling and the Control of Translation

Dufner, A., & Thomas, G. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4683 · Cited by 676 · see citing works

Molecular mechanisms underlying ErbB2/HER2 action in breast cancer

Harari, D., & Yarden, Y. (2000) · Oncogene · doi:10.1038/sj.onc.1203973 · Cited by 636 · see citing works

NF1 Tumor Suppressor Gene Function

Cichowski, K. M., & Jacks, T. (2001) · Cell · doi:10.1016/s0092-8674(01)00245-8 · Cited by 603 · see citing works

Negative Regulation of Cytokine Signaling Pathways

Yasukawa, H., Sasaki, A. T., & Yoshimura, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.143 · Cited by 596 · see citing works

The biology of stem cell factor and its receptor C-kit

Ashman, L. K. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00076-x · Cited by 578 · see citing works

Transformation of hematopoietic cells by BCR/ABL requires activation of a PI‐3k/Akt‐dependent pathway

Skorski, T., Bellacosa, A., Nieborowska‐Skorska, M., Majewski, M., Martinez, R., Choi, J. K., Trotta, R., Wlodarski, P., Perrotti, D., Chan, T. O., et al. (1997) · The EMBO Journal · doi:10.1093/emboj/16.20.6151 · Cited by 567 · see citing works

Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia

Meshinchi, S., Woods, W. G., Stirewalt, D. L., Sweetser, D. A., Buckley, J. D., Tjoa, T. K., Bernstein, I. D., & Radich, J. P. (2001) · Blood · doi:10.1182/blood.v97.1.89 · Cited by 516 · see citing works

Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse

Cristofano, A. D., Acetis, M. D., Koff, A., Cordon‐Cardo, C., & Pandolfi, P. P. (2001) · Nature Genetics · doi:10.1038/84879 · Cited by 498 · see citing works

Fusion of TEL, the ETS-Variant Gene 6 (ETV6), to the Receptor-Associated Kinase JAK2 as a Result of t(9; 12) in a Lymphoid and t(9; 15; 12) in a Myeloid Leukemia

Peeters, P. J., Raynaud, S., Cools, J., Włodarska, I., Grosgeorge, J., Philip, P., Monpoux, F., Rompaey, L. V., Baens, M., BERGHE, H. V. D., et al. (1997) · Blood · doi:10.1182/blood.v90.7.2535 · Cited by 491 · see citing works

Activating SRC mutation in a subset of advanced human colon cancers

Irby, R. B., Mao, W., Coppola, D., Kang, J., Loubeau, J. M., Trudeau, W., Karl, R., Fujita, D. J., Jove, R., & Yeatman, T. J. (1999) · Nature Genetics · doi:10.1038/5971 · Cited by 489 · see citing works

The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells

Williams, M. R., Arthur, J. S. C., Balendran, A., KAAY, J. V. D., Poli, V., Cohen, P., & Alessi, D. R. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00441-3 · Cited by 471 · see citing works

Effect of c-kit Mutation on Prognosis of Gastrointestinal Stromal Tumors

谷口, 正. (2001) · Cited by 438 · see citing works

c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGFPreprint

Plattner, R., Kadlec, L., DeMali, K. A., Kazlauskas, A., & Pendergast, A. M. (1999) · Genes & Development · doi:10.1101/gad.13.18.2400 · Cited by 428 · see citing works

A Coiled-Coil Oligomerization Domain of Bcr Is Essential for the Transforming Function of Bcr-Abl Oncoproteins

McWhirter, J. R., Galasso, D. L., & Wang, J. Y. J. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7587 · Cited by 422 · see citing works

Transformation of Chicken Cells by the Gene Encoding the Catalytic Subunit of PI 3-Kinase

Chang, H. W., Aoki, M., Fruman, D. A., Auger, K. R., Bellacosa, A., Tsichlis, P. N., Cantley, L. C., Roberts, T. M., & Vogt, P. K. (1997) · Science · doi:10.1126/science.276.5320.1848 · Cited by 412 · see citing works

Cellular Signaling

Toker, A., & Newton, A. C. (2000) · Cell · doi:10.1016/s0092-8674(00)00110-0 · Cited by 410 · see citing works

Selected glimpses into the activation and function of Src kinase

Bjorge, J. D., Jakymiw, A., & Fujita, D. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203923 · Cited by 409 · see citing works

THE CROONIAN LECTURE 1997. The phosphorylation of proteins on tyrosine: its role in cell growth and disease

Hunter, T. R. (1998) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1998.0228 · Cited by 409 · see citing works

Structures of Src-family tyrosine kinases

Sicheri, F., & Kuriyan, J. (1997) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(97)80146-7 · Cited by 381 · see citing works

Blockade of the Bcr-Abl Kinase Activity Induces Apoptosis of Chronic Myelogenous Leukemia Cells by Suppressing Signal Transducer and Activator of Transcription 5–Dependent Expression of Bcl-XL

Horita, M., Andreu, E. J., Benito, A., Arbona, C., Sanz, C., Benet, I., Prósper, F., & Fernández-Luna, J. L. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.6.977 · Cited by 366 · see citing works

The Kit receptor promotes cell survival via activation of PI 3-kinase and subsequent Akt-mediated phosphorylation of Bad on Ser136

Blume‐Jensen, P., Janknecht, R., & Hunter, T. R. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70302-1 · Cited by 360 · see citing works

Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors.

Taniguchi, M., Nishida, T., Hirota, S., Isozaki, K., Ito, T., Nomura, T., Matsuda, H., & Kitamura, Y. (1999) · PubMed · Cited by 356 · see citing works

Role of the p53-homologue p73 in E2F1-induced apoptosis

Stiewe, T., & Pützer, B. M. (2000) · Nature Genetics · doi:10.1038/82617 · Cited by 351 · see citing works

Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR–ABL tyrosine kinase

Vigneri, P. G., & Wang, J. Y. J. (2001) · Nature Medicine · doi:10.1038/84683 · Cited by 333 · see citing works

Autoregulatory Mechanisms in Protein-tyrosine Kinases

Hubbard, S. R., Mohammadi, M., & Schlessinger, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.20.11987 · Cited by 317 · see citing works

A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt

Aoki, M., Blazek, E., & Vogt, P. K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.136 · Cited by 306 · see citing works

Stat5 Is Essential for the Myelo- and Lymphoproliferative Disease Induced by TEL/JAK2

Schwaller, J., Parganas, E., Wang, D., Cain, D., Aster, J. C., Williams, I. R., Lee, C., Gerthner, R., Kitamura, T., Frantsve‐Hawley, J., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00067-8 · Cited by 303 · see citing works

The RET proto-oncogene in human cancers

Jhiang, S. M. (2000) · Oncogene · doi:10.1038/sj.onc.1203857 · Cited by 297 · see citing works

The protein kinases of Caenorhabditis elegans : A model for signal transduction in multicellular organisms

Plowman, G. D., Sudarsanam, S., Bingham, J., Whyte, D. B., & Hunter, T. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13603 · Cited by 278 · see citing works

Regulation of cell death by the Abl tyrosine kinase

Wang, J. Y. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203878 · Cited by 278 · see citing works

Identification and characterization of a new oncogene derived from the regulatory subunit of phosphoinositide 3‐kinase

Jiménez, C., Jones, D. R., Rodriguez‐Viciana, P., González-Garcı́a, A., Leonardo, E., Wennström, S., von Kobbe, C., Toran, J. L., R‐Borlado, L., Calvo, V., et al. (1998) · The EMBO Journal · doi:10.1093/emboj/17.3.743 · Cited by 269 · see citing works

STAT3 as an Adapter to Couple Phosphatidylinositol 3-Kinase to the IFNAR1 Chain of the Type I Interferon Receptor

Pfeffer, L. M., Mullersman, J. E., Pfeffer, S. R., Murti, A., Shi, W., & Yang, C. H. (1997) · Science · doi:10.1126/science.276.5317.1418 · Cited by 258 · see citing works

Stem Cell Factor/c-kit Up-regulates Cyclin D3 and Promotes Cell Cycle Progression via the Phosphoinositide 3-Kinase/p70 S6 Kinase Pathway in Spermatogonia

Feng, L., Ravindranath, N., & Dym, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002218200 · Cited by 252 · see citing works

BCR/ABL Regulates Expression of the Cyclin-dependent Kinase Inhibitor p27Kip1 through the Phosphatidylinositol 3-Kinase/AKT Pathway

Gesbert, F., Sellers, W. R., Signoretti, S., Loda, M. F., & Griffin, J. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007291200 · Cited by 218 · see citing works

Phosphorylation of Shc by Src family kinases is necessary for stem cell factor receptor/c-kit mediated activation of the Ras/MAP kinase pathway and c-fos induction

Lennartsson, J., Blume‐Jensen, P., Hermanson, M., Pontén, E., Carlberg, M., & Rönnstrand, L. (1999) · Oncogene · doi:10.1038/sj.onc.1202929 · Cited by 209 · see citing works

SHP-1 Binds and Negatively Modulates the c-Kit Receptor by Interaction with Tyrosine 569 in the c-Kit Juxtamembrane Domain

Kozlowski, M., Larose, L., Lee, F., Le, D. M., Rottapel, R. K., & Siminovitch, K. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.4.2089 · Cited by 204 · see citing works

Phosphorylation of Tyrosine Residues in the Kinase Domain and Juxtamembrane Region Regulates the Biological and Catalytic Activities of Eph Receptors

Binns, K. L., Taylor, P. P., Sicheri, F., Pawson, T. J., & Holland, S. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.13.4791-4805.2000 · Cited by 204 · see citing works

A nuclear protein tyrosine phosphatase is required for the inactivation of Stat1

Haspel, R. L., & Darnell, J. E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10188 · Cited by 203 · see citing works

Regulation of Colony-Stimulating Factor 1 Receptor Signaling by the SH2 Domain-Containing Tyrosine Phosphatase SHPTP1

Chen, H. E., Chang, S. B., Trüb, T., & Neel, B. G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3685 · Cited by 195 · see citing works

Receptor signaling: When dimerization is not enough

Jiang, G., & Hunter, T. R. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80357-1 · Cited by 181 · see citing works

Structure, expression and chromosomal mapping of c-akt: relationship to v-akt and its implications.

Bellacosa, A., Franke, T. F., González, M. E., Datta, K., Taguchi, T., Gardner, J., Cheng, J. Q., Testa, J. R., & Tsichlis, P. N. (1993) · PubMed · Cited by 176 · see citing works

Cell-cycle-dependent translational control.

Pyronnet, S., & Sonenberg, N. (2001) · Current Opinion in Genetics and Development · doi:10.1016/s0959-437x(00)00150-7 · Cited by 176 · see citing works

The kit ligand encoded at the murine Steel locus: a pleiotropic growth and differentiation factor

Besmer, P. (1991) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(91)90111-b · Cited by 173 · see citing works

RNA hyperediting and alternative splicing of hematopoietic cell phosphatase (PTPN6) gene in acute myeloid leukemia

Beghini, A., Ripamonti, C. B., Peterlongo, P., Roversi, G., Cairoli, R., Morra, E., & Larizza, L. (2000) · Human Molecular Genetics · doi:10.1093/oxfordjournals.hmg.a018921 · Cited by 169 · see citing works

Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1

Piao, X., Paulson, R. F., van der Geer, P., Pawson, T. J., & Bernstein, A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14665 · Cited by 160 · see citing works

Signalling by the W/Kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase Shp1

Paulson, R. F., Vesely, S. M., Siminovitch, K. A., & Bernstein, A. (1996) · Nature Genetics · doi:10.1038/ng0796-309 · Cited by 159 · see citing works

Cancer and genomics

Futreal, P. A., Kasprzyk, A., Birney, E., Mullikin, J. C., Wooster, R., & Stratton, M. R. (2001) · Nature · doi:10.1038/35057046 · Cited by 152 · see citing works

Structure of the Tie2 RTK Domain

Shewchuk, L. M., Hassell, A. M., Ellis, B., Holmes, W. D., Davis, R., Horne, E., Kadwell, S. H., McKee, D. D., & Moore, J. T. (2000) · Structure · doi:10.1016/s0969-2126(00)00516-5 · Cited by 147 · see citing works

p70s6k Integrates Phosphatidylinositol 3-Kinase and Rapamycin-Regulated Signals for E2F Regulation in T Lymphocytes

Brennan, P., Babbage, J., Thomas, G., & Cantrell, D. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.4729 · Cited by 147 · see citing works

C‐cell hyperplasia, pheochromocytoma and sympathoadrenal malformation in a mouse model of multiple endocrine neoplasia type 2B

Smith‐Hicks, C. L., Sizer, K. C., Powers, J. F., Tischler, A. S., & Costantini, F. D. (2000) · The EMBO Journal · doi:10.1093/emboj/19.4.612 · Cited by 145 · see citing works

Jaks and stats in cytokine signaling

Ihle, J. N., Nosaka, T., Thierfelder, W. E., Quelle, F. W., & Shimoda, K. (1997) · Stem Cells · doi:10.1002/stem.5530150814 · Cited by 109 · see citing works

Colorectal carcinomas in mice lacking the catalytic subunit of PI(3)Kγ

Sasaki, T., Irie-Sasaki, J., Horie, Y., Bachmaier, K., Fata, J. E., Li, M., Suzuki, A., Bouchard, D., Ho, A., Redston, M. S., et al. (2000) · Nature · doi:10.1038/35022585 · Cited by 100 · see citing works

Enhanced Phosphatidylinositol 3-Kinase Activity and High Phosphorylation State of Its Downstream Signalling Molecules Mediated by Ret with the MEN 2B Mutation

Murakami, H., Iwashita, T., Asai, N., Shimono, Y., Iwata, Y., Kawai, K., & Takahashi, M. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1186 · Cited by 96 · see citing works

Regulation of Protein Kinase B

Meier, R., & Hemmings, B. A. (1999) · Journal of Receptors and Signal Transduction · doi:10.3109/10799899909036639 · Cited by 83 · see citing works

The multiple endocrine neoplasia type 2B point mutation switches the specificity of the Ret tyrosine kinase towards cellular substrates that are susceptible to interact with Crk and Nck

Bocciardi, R., Mograbi, B., Pasini, B., Borrello, M. G., Pierotti, M. A., Bourget, I., Fischer, S., Romeo, G., & Rossi, B. (1997) · Oncogene · doi:10.1038/sj.onc.1201413 · Cited by 75 · see citing works

A single amino acid substitution in a WW‐like domain of diverse members of the PDGF receptor subfamily of tyrosine kinases causes constitutive receptor activation

Irusta, P. M., & DiMaio, D. (1998) · The EMBO Journal · doi:10.1093/emboj/17.23.6912 · Cited by 68 · see citing works

Signal Transduction by the Receptor Tyrosine Kinase Ret

van Weering, D. H. J., & Bos, J. L. (1998) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-46870-4_18 · Cited by 66 · see citing works

Cooperation between STAT5 and phosphatidylinositol 3-kinase in the IL-3-dependent survival of a bone marrow derived cell line

Santos, S. C. R., Dumon, S., Mayeux, P., Gisselbrecht, S., & Gouilleux, F. (2000) · Oncogene · doi:10.1038/sj.onc.1203418 · Cited by 62 · see citing works

Functional Cooperation of the Interleukin-2 Receptor β Chain and Jak1 in Phosphatidylinositol 3-Kinase Recruitment and Phosphorylation

Migone, T., Rodig, S. J., Cacalano, N. A., Berg, M., Schreiber, R. D., & Leonard, W. J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6416 · Cited by 54 · see citing works

Functional domains in plant shoot meristems

Brand, U., Hobe, M., & Simon, R. G. (2001) · BioEssays · doi:10.1002/1521-1878(200102)23:2 · Cited by 49 · see citing works

Interaction of the receptor tyrosine kinase p145c‐kit with the p210bcr/abl kinase in myeloid cells

Hallek, M. J., Danhauser-riedl, S., Herbst, R., Warmuth, M., Winkler, A., Kolb, H., Druker, B. J., Griffin, J. D., Emmerich, B., & Ullrich, A. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.6102053.x · Cited by 41 · see citing works

PI3 Kinase mediates transformation of hematopoietic cells by the V816 c-kit mutant

Chian, R., Young, S., Danilkovitch‐Miagkova, A., Rönnstrand, L., Leonard, E. J., Ferrao, P., Ashman, L. K., & Linnekin, D. (2000) · Experimental Hematology · doi:10.1016/s0301-472x(00)00562-2 · Cited by 8 · see citing works

The protein kinase complement of the human genome

Manning, G., Whyte, D. B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002) · Science · doi:10.1126/science.1075762 · Cited by 8,145 · see citing works

Cell Signaling by Receptor Tyrosine Kinases

Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929 · see citing works

EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib

Pao, W., Miller, V., Zakowski, M., Doherty, J., Politi, K., Sarkaria, I., Singh, B., Heelan, R., Rusch, V., Fulton, L., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405220101 · Cited by 4,338 · see citing works

Development by Self-Digestion

Levine, B., & Klionsky, D. J. (2004) · Developmental Cell · doi:10.1016/s1534-5807(04)00099-1 · Cited by 3,671 · see citing works

STATs: transcriptional control and biological impact

Levy, D. E., & Darnell, J. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm909 · Cited by 3,201 · see citing works

Autophagy in Health and Disease: A Double-Edged Sword

Shintani, T., & Klionsky, D. J. (2004) · Science · doi:10.1126/science.1099993 · Cited by 2,531 · see citing works

PI3K/Akt signalling pathway and cancer

Vara, J. Á. F., Casado, E., de Castro, J., Cejas, P., Belda-Iniesta, C., & González-Barón, M. (2003) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2003.07.007 · Cited by 2,446 · see citing works

Global Survey of Phosphotyrosine Signaling Identifies Oncogenic Kinases in Lung Cancer

Rikova, K., Guo, A., Zeng, Q., Possemato, A., Yu, J., Haack, H., Nardone, J., Lee, K., Reeves, C., Li, Y., et al. (2007) · Cell · doi:10.1016/j.cell.2007.11.025 · Cited by 2,317 · see citing works

The STATs of cancer — new molecular targets come of age

Yu, H., & Jove, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1275 · Cited by 2,278 · see citing works

Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery

Hennessy, B. T., Smith, D. L., Ram, P. T., Lu, Y., & Mills, G. B. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1902 · Cited by 2,183 · see citing works

Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells

Al-Nedawi, K. N. I., Meehan, B., Micallef, J., Lhotak, V., May, L. L., Guha, A., & Rak, J. W. (2008) · Nature Cell Biology · doi:10.1038/ncb1725 · Cited by 2,037 · see citing works

Ageing as a Risk Factor for Disease

Niccoli, T., & Partridge, L. (2012) · Current Biology · doi:10.1016/j.cub.2012.07.024 · Cited by 1,831 · see citing works

Molecular mechanisms of drug resistance

Longley, D., & Johnston, P. (2005) · The Journal of Pathology · doi:10.1002/path.1706 · Cited by 1,686 · see citing works

The role of autophagy in cancer development and response to therapy

Kondo, Y., Kanzawa, T., Sawaya, R. A., & Kondo, S. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1692 · Cited by 1,657 · see citing works

The protein kinase B/Akt signalling pathway in human malignancy

Nicholson, K. M., & Anderson, N. G. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00271-6 · Cited by 1,631 · see citing works

Protein Analysis by Shotgun/Bottom-up Proteomics

Zhang, Y., Fonslow, B. R., Shan, B., Baek, M.-C., & Yates, J. R. (2013) · Chemical Reviews · doi:10.1021/cr3003533 · Cited by 1,491 · see citing works

The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review)

Ardito, F., Giuliani, M., PERRONE, D., Troiano, G., & Muzio, L. L. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3036 · Cited by 1,349 · see citing works

Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma

Parsa, A. T., Waldron, J. S., Panner, A., Crane, C. A., Parney, I. F., Barry, J. J., Cachola, K. E., Murray, J. C., Tihan, T., Jensen, M. C., et al. (2006) · Nature Medicine · doi:10.1038/nm1517 · Cited by 1,341 · see citing works

Kinase-targeted cancer therapies: progress, challenges and future directions

Bhullar, K. S., Orrego-Lagarón, N., McGowan, E. M., Parmar, I., Jha, A., Hubbard, B. P., & Rupasinghe, H. P. V. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0804-2 · Cited by 1,260 · see citing works

PI3K-Akt pathway: Its functions and alterations in human cancer

Osaki, M., Oshimura, M., & Ito, H. (2004) · APOPTOSIS · doi:10.1023/b:appt.0000045801.15585.dd · Cited by 1,266 · see citing works

The discovery of receptor tyrosine kinases: targets for cancer therapy

Gschwind, A., Fischer, O. M., & Ullrich, A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1360 · Cited by 1,227 · see citing works

Transcription factors as targets for cancer therapy

Darnell, J. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc906 · Cited by 1,194 · see citing works

Immunoaffinity profiling of tyrosine phosphorylation in cancer cells

Rush, A. J., Moritz, A., Lee, K. A., Guo, A., Goss, V. L., Spek, E. J., Zhang, H., Zha, X., Polakiewicz, R. D., & Comb, M. J. (2004) · Nature Biotechnology · doi:10.1038/nbt1046 · Cited by 1,126 · see citing works

Role of Tyrosine Kinase Inhibitors in Cancer Therapy

Arora, A., & Scholar, E. M. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.084145 · Cited by 1,016 · see citing works

Engineering Customized Cell Sensing and Response Behaviors Using Synthetic Notch Receptors

Morsut, L., Roybal, K. T., Xiong, X., Gordley, R. M., Coyle, S. M., Thomson, M., & Lim, W. A. (2016) · Cell · doi:10.1016/j.cell.2016.01.012 · Cited by 1,002 · see citing works

Ligand-Induced, Receptor-Mediated Dimerization and Activation of EGF Receptor

Schlessinger, J. (2002) · Cell · doi:10.1016/s0092-8674(02)00966-2 · Cited by 995 · see citing works

Src family kinases, key regulators of signal transduction

Parsons, S. J., & Parsons, J. T. (2004) · Oncogene · doi:10.1038/sj.onc.1208160 · Cited by 942 · see citing works

Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia

Emamian, E. S., Hall, D., Birnbaum, M. J., Karayiorgou, M., & Gogos, J. A. (2004) · Nature Genetics · doi:10.1038/ng1296 · Cited by 914 · see citing works

Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma

Janoueix‐Lerosey, I., Lequin, D., Brugières, L., Ribeiro, A., de Pontual, L., Combaret, V., Raynal, V., Puisieux, A., Schleiermacher, G., Pierron, G., et al. (2008) · Nature · doi:10.1038/nature07398 · Cited by 893 · see citing works

Insulin-Like Growth Factor-I Receptor Signaling and Resistance to Trastuzumab (Herceptin)

Lu, Y., Zi, X., Zhao, Y., Mascarenhas, D. D., & Pollak, M. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.24.1852 · Cited by 884 · see citing works

Arsenic-induced oxidative stress and its reversibility

Flora, S. J. S. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.04.008 · Cited by 825 · see citing works

EGFR Mutations in Non–Small-Cell Lung Cancer: Analysis of a Large Series of Cases and Development of a Rapid and Sensitive Method for Diagnostic Screening With Potential Implications on Pharmacologic Treatment

Marchetti, A., Martella, C., Felicioni, L., Barassi, F., Salvatore, S., Chella, A., Camplese, P., Iarussi, T., Mucilli, F., Mezzetti, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.043 · Cited by 780 · see citing works

Multicomponent therapeutics for networked systems

Keith, C. T., Borisy, A. A., & Stockwell, B. R. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1609 · Cited by 769 · see citing works

Vascular endothelial growth factor in eye disease

Penn, J. S., Madan, A., Caldwell, R. B., Bartoli, M., Caldwell, R. W., & Hartnett, M. E. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.05.001 · Cited by 768 · see citing works

Phosphotyrosine interactome of the ErbB‐receptor kinase family

Schulze, W. X., Deng, L., & Mann, M. (2005) · Molecular Systems Biology · doi:10.1038/msb4100012 · Cited by 753 · see citing works

Targeting signalling pathways and the immune microenvironment of cancer stem cells — a clinical update

Clara, J., Monge, C., Yang, Y., & Takebe, N. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0293-2 · Cited by 752 · see citing works

An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms

Zou, H. Y., Li, Q., Lee, J. H., Arango, M. E., McDonnell, S. R. P., Yamazaki, S., Koudriakova, T. B., Alton, G., Cui, J. J., Kung, P., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4443 · Cited by 749 · see citing works

Ubiquitylation and cell signaling

Haglund, K., & Đikić, I. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600808 · Cited by 736 · see citing works

An atlas of substrate specificities for the human serine/threonine kinome

Johnson, J. L., Yaron, T. M., Huntsman, E. M., Kerelsky, A., Song, J., Regev, A., Lin, T.-Y., Liberatore, K., Cizin, D. M., Cohen, B. M., et al. (2023) · Nature · doi:10.1038/s41586-022-05575-3 · Cited by 728 · see citing works

Nanowire nanosensors

Patolsky, F., & Lieber, C. M. (2005) · Materials Today · doi:10.1016/s1369-7021(05)00791-1 · Cited by 705 · see citing works

Epidermal Growth Factor Receptor Targeting in Cancer

Mendelsohn, J. M., & Baselga, J. M. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2006.04.003 · Cited by 693 · see citing works

Essential roles of PI(3)K–p110β in cell growth, metabolism and tumorigenesis

Jia, S., Liu, Z., Zhang, S., Liu, P., Zhang, L., Lee, S., Zhang, J., Signoretti, S., Loda, M. F., Roberts, T. M., et al. (2008) · Nature · doi:10.1038/nature07091 · Cited by 691 · see citing works

The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease

Lu, K. P., & Zhou, X. Z. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2261 · Cited by 682 · see citing works

Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics

Blagoev, B., Ong, S., Kratchmarova, I., & Mann, M. (2004) · Nature Biotechnology · doi:10.1038/nbt1005 · Cited by 684 · see citing works

Nuclear retinoid receptors and the transcription of retinoid-target genes

Bastien, J., & Rochette-Egly, C. (2004) · Gene · doi:10.1016/j.gene.2003.12.005 · Cited by 773 · see citing works

A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells

Kwiatkowski, D. J. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.5.525 · Cited by 667 · see citing works

Tyrosine phosphorylation: thirty years and counting

Hunter, T. R. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.01.028 · Cited by 664 · see citing works

Protein-tyrosine phosphatases and cancer

Östman, A., Hellberg, C. B., & Böhmer, F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1837 · Cited by 657 · see citing works

Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma

Christensen, J. G., Zou, H. Y., Arango, M. E., Li, Q., Lee, J. H., McDonnell, S. R. P., Yamazaki, S., Alton, G., Mroczkowski, B., & Los, G. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0365 · Cited by 648 · see citing works

Systematic discovery of multicomponent therapeutics

Borisy, A. A., Elliott, P. J., Hurst, N. W., Lee, M. S., Lehár, J., Price, E. R., Serbedzija, G., Zimmermann, G. R., Foley, M. A., Stockwell, B. R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1337088100 · Cited by 620 · see citing works

Structural Basis for the Autoinhibition and STI-571 Inhibition of c-Kit Tyrosine Kinase

Mol, C. D., Dougan, D. R., Schneider, T. R., Skene, R. J., Kraus, M. L., Scheibe, D. N., Snell, G., Zou, H., Sang, B., & Wilson, K. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403319200 · Cited by 634 · see citing works

Tyrosine kinase – Role and significance in Cancer

Paul, M. K., & Mukhopadhyay, A. K. (2004) · International Journal of Medical Sciences · doi:10.7150/ijms.1.101 · Cited by 627 · see citing works

Mutations in a signalling pathway

Parsons, D. W., Wang, T., Samuels, Y., Bardelli, A., Cummins, J. M., Wood, L. D., Silliman, N., Ptak, J., Szabo, S., Willson, J. K. V., et al. (2005) · Nature · doi:10.1038/436792a · Cited by 599 · see citing works

The deaf and the dumb: the biology of ErbB-2 and ErbB-3

Citri, A. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00101-5 · Cited by 591 · see citing works

Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle

Daub, H., Olsen, J. V., Bairlein, M., Gnad, F., Oppermann, F. S., Körner, R., Greff, Z., Kéri, G., Stemmann, O., & Mann, M. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.07.007 · Cited by 594 · see citing works

Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids

Rademakers, R., Baker, M., Nicholson, A. M., Rutherford, N. J., Finch, N., Soto-Ortolaza, A., Lash, J., Wider, C., Wojtas, A., DeJesus-Hernandez, M., et al. (2012) · Nature Genetics · doi:10.1038/ng.1027 · Cited by 571 · see citing works

PhosphoSite: A bioinformatics resource dedicated to physiological protein phosphorylation

Hornbeck, P. V., Chabra, I., Kornhauser, J. M., Skrzypek, E., & Zhang, B. (2004) · PROTEOMICS · doi:10.1002/pmic.200300772 · Cited by 590 · see citing works

Akt Maintains Cell Size and Survival by Increasing mTOR-dependent Nutrient Uptake

Edinger, A. L., & Thompson, C. B. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.01-12-0584 · Cited by 589 · see citing works

Activation of the PI3K/Akt pathway and chemotherapeutic resistance

West, K. A., Castillo, S. S., & Dennis, P. A. (2002) · Drug Resistance Updates · doi:10.1016/s1368-7646(02)00120-6 · Cited by 583 · see citing works

Biological Characterization of ARRY-142886 (AZD6244), a Potent, Highly Selective Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor

Yeh, T. C., Marsh, V., Bernat, B. A., Ballard, J., Colwell, H., Evans, R. J., Parry, J., Smith, D. J., Brandhuber, B. J., Gross, S. D., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1150 · Cited by 583 · see citing works

Decoding signalling networks by mass spectrometry-based proteomics

Choudhary, C., & Mann, M. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2900 · Cited by 575 · see citing works

Mechanism of Divergent Growth Factor Effects in Mesenchymal Stem Cell Differentiation

Kratchmarova, I., Blagoev, B., Haack‐Sørensen, M., Kassem, M. S., & Mann, M. (2005) · Science · doi:10.1126/science.1107627 · Cited by 567 · see citing works

TOR signalling in bugs, brain and brawn

Jacinto, E., & Hall, M. N. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1018 · Cited by 560 · see citing works

PTP1B as a drug target: recent developments in PTP1B inhibitor discovery

Zhang, S., & Zhang, Z. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.03.011 · Cited by 566 · see citing works

Insulin/IGF and target of rapamycin signaling: a TOR de force in growth control.

Oldham, S., & Hafen, E. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(02)00042-9 · Cited by 574 · see citing works

Clinical proteomics: translating benchside promise into bedside reality

Petricoin, E. F., Zoon, K. C., Kohn, E. C., Barrett, J. C., & Liotta, L. A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd891 · Cited by 545 · see citing works

The Role of Prolactin in Mammary Carcinoma

Clevenger, C. V., Furth, P. A., Hankinson, S. E., & Schuler, L. A. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0036 · Cited by 542 · see citing works

Androgen receptor signaling in prostate cancer development and progression

Tindall, D. J., & Lonergan, P. E. (2011) · Journal of Carcinogenesis · doi:10.4103/1477-3163.83937 · Cited by 544 · see citing works

Label-free detection of small-molecule–protein interactions by using nanowire nanosensors

Wang, W. U., Chen, C., Lin, K.-H., Fang, Y. Z., & Lieber, C. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406368102 · Cited by 535 · see citing works

Receptor tyrosine kinases: mechanisms of activation and signaling

Hubbard, S. R., & Miller, W. T. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.02.010 · Cited by 535 · see citing works

Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth.

Gupta, K., Kshirsagar, S. A., Chang, L., Schwartz, R. E., Law, P., Yee, D., & Hebbel, R. P. (2002) · PubMed · Cited by 527 · see citing works

Issues and progress with protein kinase inhibitors for cancer treatment

Dancey, J. E., & Sausville, E. A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1066 · Cited by 524 · see citing works

Clinical, Cellular, and Molecular Aspects of Cancer Invasion

Mareel, M., & Leroy, A. (2003) · Physiological Reviews · doi:10.1152/physrev.00024.2002 · Cited by 521 · see citing works

Mutational Analysis of the Tyrosine Phosphatome in Colorectal Cancers

Wang, Z., Shen, D., Parsons, D. W., Bardelli, A., Sager, J. A., Szabo, S., Ptak, J., Silliman, N., Peters, B. A., van der Heijden, M. S., et al. (2004) · Science · doi:10.1126/science.1096096 · Cited by 521 · see citing works

Molecular Recognition of Protein Kinase Binding Pockets for Design of Potent and Selective Kinase Inhibitors

Liao, J.-L. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0608107 · Cited by 512 · see citing works

c-Met: Structure, functions and potential for therapeutic inhibition

Ma, P. C., Maulik, G., Christensen, J. G., & Salgia, R. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1023768811842 · Cited by 506 · see citing works

HTRF: A Technology Tailored for Drug Discovery - A Review of Theoretical Aspects and Recent Applications

Degorce, F. (2009) · Current Chemical Genomics · doi:10.2174/1875397300903010022 · Cited by 501 · see citing works

FLT3: ITDoes matter in leukemia

Levis, M. J., & Small, D. (2003) · Leukemia · doi:10.1038/sj.leu.2403099 · Cited by 494 · see citing works

Microvesicles as mediators of intercellular communication in cancer—the emerging science of cellular ‘debris’

Lee, T. H., D’Asti, E., Magnus, N., Al-Nedawi, K. N. I., Meehan, B., & Rak, J. W. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0250-3 · Cited by 496 · see citing works

Insulin, Insulin-Like Growth Factor-I (IGF-I), IGF Binding Proteins, Their Biologic Interactions, and Colorectal Cancer

Sandhu, M. S. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.13.972 · Cited by 495 · see citing works

Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks

Wolf‐Yadlin, A., Hautaniemi, S., Lauffenburger, D. A., & White, F. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608638104 · Cited by 494 · see citing works

Protein kinase CK2: a challenge to canons

Pinna, L. A. (2002) · Journal of Cell Science · doi:10.1242/jcs.00074 · Cited by 491 · see citing works

Mutational Analysis of the Tyrosine Kinome in Colorectal Cancers

Bardelli, A., Parsons, D. W., Silliman, N., Ptak, J., Szabo, S., Saha, S., Markowitz, S. D., Willson, J. K. V., Parmigiani, G., Kinzler, K. W., et al. (2003) · Science · doi:10.1126/science.1082596 · Cited by 485 · see citing works

A Myristoyl/Phosphotyrosine Switch Regulates c-Abl

Hantschel, O. D., Nagar, B., Guettler, S., Kretzschmar, J., Dorey, K., Kuriyan, J., & Superti‐Furga, G. (2003) · Cell · doi:10.1016/s0092-8674(03)00191-0 · Cited by 482 · see citing works

Targeting Tyrosine Kinases in Cancer: The Second Wave

Baselga, J. M. (2006) · Science · doi:10.1126/science.1125951 · Cited by 478 · see citing works

Molecular Mechanisms Underlying the Activation of Mammalian Primordial Follicles

Adhikari, D., & Liu, K. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0048 · Cited by 483 · see citing works

A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo

Levis, M. J., Allebach, J., Tse, K.-F., Zheng, R., Baldwin, B. R., Smith, B. D., Jones‐Bolin, S., Ruggeri, B., Dionne, C. A., & Small, D. (2002) · Blood · doi:10.1182/blood.v99.11.3885 · Cited by 472 · see citing works

Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets

Hommes, D. W., Peppelenbosch, M. P., & van Deventer, S. J. H. (2002) · Gut · doi:10.1136/gut.52.1.144 · Cited by 474 · see citing works

Regulation of MAPKs by growth factors and receptor tyrosine kinases

Katz, M., Amit, I., & Yarden, Y. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.01.002 · Cited by 468 · see citing works

Protein microarrays: Meeting analytical challenges for clinical applications

Liotta, L. A., Espina, V. A., Mehta, A. I., Calvert, V. S., Rosenblatt, K. P., Geho, D. H., Munson, P. J., Young, L., Wulfkuhle, J. D., & Petricoin, E. F. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00086-2 · Cited by 446 · see citing works

Common and Distinct Elements in Cellular Signaling via EGF and FGF Receptors

Schlessinger, J. (2004) · Science · doi:10.1126/science.1105396 · Cited by 438 · see citing works

The Role of Protein Loops and Linkers in Conformational Dynamics and Allostery

Papaleo, E., Saladino, G., Lambrughi, M., Lindorff‐Larsen, K., Gervasio, F. L., & Nussinov, R. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00623 · Cited by 426 · see citing works

Integration of IGF, FGF, and anti-BMP signals via Smad1 phosphorylation in neural inductionPreprint

Pera, E. M., Ikeda, A., Eivers, E., & Robertis, E. M. D. (2003) · Genes & Development · doi:10.1101/gad.1153603 · Cited by 421 · see citing works

ON THE FOUNDATIONS OF CANCER MODELLING: SELECTED TOPICS, SPECULATIONS, AND PERSPECTIVES

Bellomo, N., LI, N. K., & Maini, P. K. (2008) · Mathematical Models and Methods in Applied Sciences · doi:10.1142/s0218202508002796 · Cited by 420 · see citing works

RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis

Lipkowitz, S., & Weissman, A. M. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3120 · Cited by 415 · see citing works

Transcription Factors in Liver Development, Differentiation, and Regeneration

Costa, R. H., Kalinichenko, V. V., Holterman, A. L., & Wang, X. (2003) · Hepatology · doi:10.1016/j.hep.2003.09.034 · Cited by 408 · see citing works

PTEN, more than the AKT pathway

Blanco‐Aparicio, C., Renner, O., Martínez-Leal, J. F., & Carnero, A. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm052 · Cited by 403 · see citing works

Retinoic acid receptors: From molecular mechanisms to cancer therapy

di Masi, A., Leboffe, L., De Marinis, E., Pagano, F., Cicconi, L., Rochette-Egly, C., Lo-Coco, F., Ascenzi, P., & Nervi, C. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.12.003 · Cited by 403 · see citing works

The BCR-ABL Story: Bench to Bedside and Back

Wong, S., & Witte, O. N. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104753 · Cited by 402 · see citing works

The Akt kinase: Molecular determinants of oncogenicity

Aoki, M., Batista, O., Bellacosa, A., Tsichlis, P. N., & Vogt, P. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14950 · Cited by 297 · see citing works

PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling.

Paez, J., & Sellers, W. R. (2003) · PubMed · Cited by 174 · see citing works

Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic

Kang, S., Bader, A. G., & Vogt, P. K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408864102 · Cited by 827 · see citing works

Phosphatidylinositol-3 kinase dependent pathways: the role in control of cell growth, survival, and malignant transformation.

Ma, K. (2000) · PubMed · Cited by 277 · see citing works

Tyrosine Kinase Signaling Pathways in Normal and Cancer Cells

Marcinkowska, E., & Gocek, E. (2016) · Resistance to targeted anti-cancer therapeutics · doi:10.1007/978-3-319-46091-8_1 · Cited by 1 · see citing works